Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice

NCT00723723 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00723723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice
Lead sponsor
Organon and Co
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2009
Enrollment
555 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, hypercholesterolemia, hyperlipidemia